DERMAL DELIVERY OF A SARS-COV-2 SUBUNIT VACCINE INDUCES IMMUNOGENICITY AGAINST VARIANTS OF CONCERN

The ongoing coronavirus disease 2019 (COVID-19) pandemic continues to disrupt essential Right Rear Endcap health services in 90 percent of countries today.The spike (S) protein found on the surface of the causative agent, the SARS-CoV-2 virus, has been the prime target for current vaccine research since antibodies directed against the S protein wer